Prevalence, knowledge, and treatment of transient ischemic attacks in China.

PubWeight™: 0.87‹?›

🔗 View Article (PMID 25957333)

Published in Neurology on May 08, 2015

Authors

Yilong Wang1, Xingquan Zhao2, Yong Jiang2, Hao Li2, Limin Wang2, S Claiborne Johnston2, Liping Liu2, Ka Sing Lawrence Wong2, Chunxue Wang2, Yuesong Pan2, Jing Jing2, Jie Xu2, Xia Meng2, Mei Zhang2, Yichong Li2, Yong Zhou2, Wenhua Zhao2, Yongjun Wang1

Author Affiliations

1: From the Department of Neurology (Yilong Wang, X.Z., Y.J., H.L., L.L., C.W., Y.P., J.J., J.X., X.M., Y.Z., Yongjun Wang), Beijing Tiantan Hospital, Capital Medical University, Beijing; China National Clinical Research Center for Neurological Diseases (Yilong Wang, X.Z., H.L., L.L., C.W., Y.P., J.J., J.X., X.M., Y.Z., Yongjun Wang), Beijing; National Center for Chronic and Non-communicable Disease Control and Prevention (Y.J., L.W., M.Z., Y.L.), Chinese Center for Disease Control and Prevention (W.Z.), Beijing, China; Departments of Neurology and Epidemiology (S.C.J.), University of California, San Francisco; and Division of Neurology (K.S.L.W.), Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China. yongjunwang1962@gmail.com yilong528@gmail.com.
2: From the Department of Neurology (Yilong Wang, X.Z., Y.J., H.L., L.L., C.W., Y.P., J.J., J.X., X.M., Y.Z., Yongjun Wang), Beijing Tiantan Hospital, Capital Medical University, Beijing; China National Clinical Research Center for Neurological Diseases (Yilong Wang, X.Z., H.L., L.L., C.W., Y.P., J.J., J.X., X.M., Y.Z., Yongjun Wang), Beijing; National Center for Chronic and Non-communicable Disease Control and Prevention (Y.J., L.W., M.Z., Y.L.), Chinese Center for Disease Control and Prevention (W.Z.), Beijing, China; Departments of Neurology and Epidemiology (S.C.J.), University of California, San Francisco; and Division of Neurology (K.S.L.W.), Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.

Associated clinical trials:

China Registry of Non-disabling Ischemic Cerebrovascular Events (CR-NICE) | NCT03079674

Articles cited by this

Intraclass correlations: uses in assessing rater reliability. Psychol Bull (1979) 71.07

Prevalence and control of diabetes in Chinese adults. JAMA (2013) 11.73

Inequality in quality: addressing socioeconomic, racial, and ethnic disparities in health care. JAMA (2000) 10.51

Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med (2013) 8.76

Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70

Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet (2007) 6.29

Measuring the global burden of disease. N Engl J Med (2013) 5.84

Short-term prognosis after emergency department diagnosis of TIA. JAMA (2000) 5.00

Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke (2011) 3.94

A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol (2007) 3.56

Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ (2004) 3.47

Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol (2007) 3.19

Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke (2005) 3.00

Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology (2004) 2.36

The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology (2004) 2.34

Prevalence and knowledge of transient ischemic attack among US adults. Neurology (2003) 1.91

The China National Stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke (2011) 1.90

Self-reported transient ischemic attack and stroke symptoms: methods and baseline prevalence. The ARIC Study, 1987-1989. Am J Epidemiol (1996) 1.38

Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials. Stroke (2012) 1.30

Transient neurological attacks in the general population. Prevalence, risk factors, and clinical relevance. Stroke (1997) 1.30

Transient cerebral ischemia. Prevalence and prognosis in a biracial rural community. JAMA (1973) 1.17

The burden of stroke and transient ischemic attack in Pakistan: a community-based prevalence study. BMC Neurol (2009) 1.16

Risk factors for noncommunicable chronic diseases in women in China: surveillance efforts. Bull World Health Organ (2013) 1.06

Transient ischemic attacks in rural and urban northern Portugal: incidence and short-term prognosis. Stroke (2005) 1.04

Prevalence of stroke and transient ischemic attack in three elderly populations of central Spain. Neuroepidemiology (2008) 1.03

Short-term prognosis of stroke among patients diagnosed in the emergency department with a transient ischemic attack. Ann Emerg Med (2007) 0.92

Prevalence of stroke and transient ischemic attack in Korean elders: findings from the Korean Longitudinal Study on Health and Aging (KLoSHA). Stroke (2009) 0.88

Prevalence of stroke and transient ischaemic attack in the elderly population of an Italian rural community. Eur J Epidemiol (2003) 0.86

An epidemiologic study of cerebrovascular disease in western Japan: with special reference to transient ischemic attacks. Stroke (1987) 0.83

Epidemiology of transient ischemic attack. Front Neurol Neurosci (2013) 0.82

Short-term and long-term risk of incident ischemic stroke after transient ischemic attack. Stroke (2009) 0.78